Related Experiment Video
Updated: May 13, 2026

Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice
Published on: October 20, 2016
Chronic subdural hematoma management with MMA embolization ± surgery: Pre-existing statin therapy did not reduce
Fee Christiane Keil1, Emma Becke1, Rejane Golbach2
1Goethe University Frankfurt, University Hospital, Institute of Neuroradiology Frankfurt am Main, Germany.
Insights
Pre-existing statin therapy did not reduce chronic subdural hematoma (CSDH) recurrence after middle meningeal artery embolization (MMAE). Surgery combined with MMAE showed no recurrence, unlike MMAE alone, but further research is needed.
Area of Science:
- Neurosurgery
- Interventional Neurology
- Vascular Neurology
Background:
- Chronic subdural hematoma (CSH) recurrence is a clinical challenge.
- Statins are explored for their potential to reduce CSH recurrence rates.
- Middle meningeal artery embolization (MMAE) is an emerging treatment for CSH.
Purpose of the Study:
- To investigate whether pre-existing statin therapy influences CSH recurrence after MMAE.
- To compare recurrence rates between MMAE alone and combined surgical evacuation plus MMAE.
Main Methods:
- Retrospective analysis of 47 CSH cases treated with MMAE between January 2020 and October 2021.
- Statin exposure was defined as documented use before MMAE and continued during follow-up.
- Clinical therapy failure was defined as radiological recurrence with new neurological symptoms.
Main Results:
- The overall recurrence rate was 6.4% (3/47 cases).
- Statin use (in 38.3% of patients) was not significantly associated with reduced recurrence.
- No recurrences were observed in cases treated with combined surgery and MMAE, while MMAE alone had events.
Conclusions:
- Statin use was not associated with reduced CSH recurrence in this cohort undergoing MMAE.
- Combined surgical evacuation and MMAE demonstrated a potential benefit by avoiding recurrence.
- These exploratory findings necessitate prospective studies for confirmation due to the small sample size.
Introduction:
Adjunctive therapies such as statins have been proposed to reduce recurrence rates in chronic subdural hematoma (CSDH).
Research Question:
Does pre-existing statin therapy influence CSDH recurrence after middle meningeal artery embolization (MMAE), with or without surgical evacuation?
Material And Methods:
We retrospectively analyzed all patients who underwent MMAE for CSDH between January 2020 and October 2021 at a university hospital with a neurovascular focus. Indications were: salvage after recurrence without additional surgical drainage, first-line MMAE in patients at high surgical risk, adjunct after surgical drainage, and salvage after recurrence with additional drainage. Statin exposure referred to statins documented before MMAE and not discontinued during follow-up.Data included clinical variables, adjunctive statin and CT-based hematoma characteristics.Clinical therapy failure required radiological recurrence plus new neurological symptoms. Analyses were descriptive and exploratory.
Results:
A total of 47 CSDHs in 38 patients (9 bilateral) were treated. Clinical failures occurred in 3/47 (6.4 %) overall, by indication: 2/13 (15.4 %) salvage-without-drainage, 1/15 (6.7 %) first-line MMAE, 0/6 (0 %) adjunct-after-drainage, 0/13 (0 %) salvage-with-drainage.Statins were administered in a subset of patients. The overall recurrence rate was 6.4 %. No significant association was found between statin exposure (18/47, 38.3 % and recurrence.One patient died from contrast-induced anaphylaxis prior to embolization; no intraprocedural device related complications were recorded.
Conclusion:
In this cohort, statin use was not associated with reduced recurrence after MMAE. Combined surgery plus MMAE showed no observed recurrences, whereas events occurred after MMAE alone. Given the small sample these results are exploratory and require prospective confirmation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Atherosclerosis III: Management
Venous Thrombosis III: Interprofessional Care

